Jadlsonian epilepsy is a rare form of epilepsy characterized by recurrent seizures that typically begin in early childhood. It is named after Dr. Allen Jadlowsky, the first physician to describe this specific type of epilepsy in 1979. The condition is also known by other names, such as benign childhood epilepsy with centrotemporal spikes (BCECTS) or Rolandic epilepsy.
Children with Jadlsonian epilepsy may experience partial seizures, which affect only one part of the brain, or generalized seizures that involve the entire brain. These seizures can manifest in various ways, such as facial twitching, drooling, numbness or tingling in the face or tongue, or difficulty speaking. Seizures often occur more frequently during sleep or upon awakening.
The characteristic feature of Jadlsonian epilepsy is the presence of centrotemporal spikes (CTS) on an electroencephalogram (EEG). These spikes represent abnormal electrical activity in the brain's centrotemporal region, which is responsible for controlling motor function. Aside from the seizures, affected individuals generally have normal intellect and development.
Jadlsonian epilepsy is typically a benign condition that tends to improve or even resolve during adolescence. Antiseizure medications are often used to manage and reduce the frequency of seizures, but in many cases, treatment may not be necessary. Monitoring with regular EEGs may be required to assess the progression of the condition and ensure appropriate management.
In summary, Jadlsonian epilepsy is a relatively mild form of epilepsy that presents with seizures primarily affecting the face and mouth area. It is associated with centrotemporal spikes on EEG and generally has a favorable long-term prognosis.
